▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3454 by analyst upside · 2026-11-12
PHR
Phreesia, Inc.
Healthcare · Market Cap $795M · P/E 75.4x
ANALYST PRICE TARGET
+8.2%
implied upside to consensus target
Current Price $12.81
Consensus Target $13.87
Bull Target $19.0
Bear Target $10.0
Analysts Covering 15
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
7
Hold
6
Sell
0
52-Week Low $7.77
52-Week High $23.3
YTD Return -21.4%
FUNDAMENTALS
Market Cap $795M
P/E Ratio (TTM) 75.4x
Forward P/E 8.1x
EPS (TTM) $0.17
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $508M
Profit Margin 2.1%
52-WEEK RANGE
52-Week Low $7.77
52-Week High $23.3
Current Price $12.81
Bear Target $10.0
Bull Target $19.0
● Now $12.81 ● Target $13.87
TRADING DATA
Avg Volume 708K
YTD Return -21.4%
Analyst Count 15
Consensus Buy
Upside to Target +8.2%
Last Updated 2026-11-12

ANALYST SUMMARY

Phreesia, Inc. (PHR) is currently trading at $12.81 with a Wall Street consensus price target of $13.87, implying potential upside of 8.2% over the next 12 months. 15 analysts currently cover PHR, with a consensus rating of Buy - 60% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $10.0.

PHR operates in the Healthcare sector with a market capitalisation of $795M. The stock is down 21.4% year-to-date and is currently trading near the lower end of its 52-week range of $7.77 – $23.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PHR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-10-12 Building track record
Raymond James ↓ Downgrade
Outperform → Market Perform 2026-09-08 Building track record
DA Davidson - Reiterated
Buy → Buy 2026-09-04 Building track record
Baird - Reiterated
Neutral → Neutral 2026-09-04 Building track record
Freedom Capital Markets - Reiterated
Buy → Buy 2026-09-03 Building track record
RBC Capital reit
Outperform → Outperform 2026-09-03 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-09-03 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-09-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
21/30
Consensus clarity
16/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →